Acknowledgments
We thank Nicolas Garnier and Abel Betraoui from Probayes for their assistance with data analysis. We thank Nicolas Dubois from Biorance.
-
Research funding: The data analysis by ProbaYes and the logistical support for the study were funded by Roche Diagnostics, which did not contribute to the study design or analysis, the decision to publish results, or manuscript preparation. The investigators were not personally remunerated.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Not applicable.
-
Ethical approval: Research involving human subjects complied with all relevant national regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration (as revised in 2013), and has been approved by the authors’ Institutional Review Board (ethics committee of Avicenne hospital, rec number: CLEA-2017-041), and the Commission Nationale de l’Informatique et des Libertés, the French agency that regulates the protection of data, re-viewed and approved the study.
References
1. Mueller, C, Laule-Kilian, K, Frana, B, Rodriguez, D, Rudez, J, Scholer, A, et al.. The use of B-type natriuretic peptide in the management of elderly patients with acute dyspnoea. J Intern Med 2005;258:77–85. https://doi.org/10.1111/j.1365-2796.2005.01503.x.Search in Google Scholar
2. Olofsson, M, Boman, K. Usefulness of natriuretic peptides in primary health care: an exploratory study in elderly patients. Scand J Prim Health Care 2010;28:29–35. https://doi.org/10.3109/02813430903345074.Search in Google Scholar
3. Plichart, M, Orvoën, G, Jourdain, P, Quinquis, L, Coste, J, Escande, M, et al.. Brain natriuretic peptide usefulness in very elderly dyspnoeic patients: the BED study: BNP in very elderly dyspnoeic patients. Eur J Heart Fail 2017;19:540–8. https://doi.org/10.1002/ejhf.699.Search in Google Scholar
4. Redfield, MM, Rodeheffer, RJ, Jacobsen, SJ, Mahoney, DW, Bailey, KR, Burnett, JC. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976–82. https://doi.org/10.1016/s0735-1097(02)02059-4.Search in Google Scholar
5. Sorbets, E, Goudot, F-X, Garnier, N, Dubois, N, Betraoui, A, Bonnivard, V, et al.. Over 70 million blood analyses in nearly 600,000 French adults between 2010 and 2015 methodology of the rubidium big data study. J Clin Trial Cardiol 2018;5:1–6.Search in Google Scholar
6. Ponikowski, P, Voors, AA, Anker, SD, Bueno, H, Cleland, JGF, Coats, AJS, et al.. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129–200.10.1002/ejhf.592Search in Google Scholar PubMed
7. Hildebrandt, P, Collinson, PO, Doughty, RN, Fuat, A, Gaze, DC, Gustafsson, F, et al.. Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care†. Eur Heart J 2010;31:1881–9. https://doi.org/10.1093/eurheartj/ehq163.Search in Google Scholar
8. Gustafsson, F, Steensgaard-Hansen, F, Badskjær, J, Poulsen, AH, Corell, P, Hildebrandt, P. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail 2005;11:S15–20. https://doi.org/10.1016/j.cardfail.2005.04.022.Search in Google Scholar
9. Goudot, F, Msadek, S, Boukertouta, T, Schischmanoff, P, Meune, C. Routine use of natriuretic peptides: lessons from a Big Data analysis. Ann Clin Biochem 2021, in press. https://doi.org/10.1177/00045632211020779.Search in Google Scholar
10. Hammerer-Lercher, A, Gruson, D, Stankovic, S, Collinson, P, Suvisaari, J, Pulkki, K, et al.. Update on current practice in laboratory medicine in respect of natriuretic peptide testing for heart failure diagnosis and management in Europe. The CARdiac MArker guideline Uptake in Europe (CARMAGUE) study. Clin Chim Acta 2020;511:59–66. https://doi.org/10.1016/j.cca.2020.09.030.Search in Google Scholar
© 2021 Walter de Gruyter GmbH, Berlin/Boston
